Adicon Holdings Limited (HKG:9860)
7.18
+0.11 (1.56%)
At close: Aug 29, 2025
Adicon Holdings Revenue
Adicon Holdings had revenue of 1.27B CNY in the half year ending June 30, 2025, a decrease of -22.72%. This brings the company's revenue in the last twelve months to 2.72B, down -12.84% year-over-year. In the year 2024, Adicon Holdings had annual revenue of 2.91B, down -11.64%.
Revenue (ttm)
2.72B CNY
Revenue Growth
-12.84%
P/S Ratio
1.71
Revenue / Employee
499.35K CNY
Employees
5,445
Market Cap
5.09B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.91B | -383.72M | -11.64% |
Dec 31, 2023 | 3.30B | -1.56B | -32.15% |
Dec 31, 2022 | 4.86B | 1.48B | 43.83% |
Dec 31, 2021 | 3.38B | 637.78M | 23.26% |
Dec 31, 2020 | 2.74B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
WuXi Biologics | 21.98B |
CSPC Pharmaceutical Group | 28.49B |